B

BioPlus Co Ltd
KOSDAQ:099430

Watchlist Manager
BioPlus Co Ltd
KOSDAQ:099430
Watchlist
Price: 7 690 KRW 1.85% Market Closed
Market Cap: 433B KRW
Have any thoughts about
BioPlus Co Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one BioPlus Co Ltd stock under the Base Case scenario is 4 614.14 KRW. Compared to the current market price of 7 690 KRW, BioPlus Co Ltd is Overvalued by 40%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
4 614.14 KRW
Overvaluation 40%
Relative Value
Price
B
Worst Case
Base Case
Best Case

Valuation Multiples

8.1
P/S
P/S
Price to Sales
8.1
vs History
90
vs Industry
24
Median 3Y
7
Median 5Y
7
Industry
2.3
Forward
6.3
More Details
24.3
P/E
P/E
Price to Earnings
24.3
vs History
67
vs Industry
35
Median 3Y
18.3
Median 5Y
18.3
Industry
23.1
Forward
17.4
More Details
17.4
P/OCF
P/OCF
Price to OCF
17.4
vs History
90
vs Industry
18
Median 3Y
30.1
Median 5Y
30.1
Industry
14.2
More Details
55.2
P/FCFE
P/FCFE
Price to FCFE
55.2
vs History
25
vs Industry
27
Median 3Y
24.8
Median 5Y
24.8
Industry
20.1
More Details
3.3
P/B
P/B
Price to Book Value
3.3
vs History
90
vs Industry
30
Median 3Y
3.5
Median 5Y
3.5
Industry
2.2
More Details
6.9
EV/S
EV/S
Enterprise Value to Sales
6.9
vs History
90
vs Industry
24
Median 3Y
5.9
Median 5Y
5.9
Industry
2.4
Forward
5.4
More Details
11.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.7
vs History
90
vs Industry
27
Median 3Y
9.9
Median 5Y
9.9
Industry
5
More Details
19.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
19.3
vs History
60
vs Industry
33
Median 3Y
13.3
Median 5Y
13.3
Industry
12.7
Forward
12.4
More Details
22.8
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
22.8
vs History
50
vs Industry
36
Median 3Y
15.2
Median 5Y
15.2
Industry
17.1
Forward
17.6
More Details
14.8
EV/OCF
EV/OCF
Enterprise Value to OCF
14.8
vs History
90
vs Industry
21
Median 3Y
24.7
Median 5Y
24.7
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
3
Median 3Y
-18.8
Median 5Y
-11.8
Industry
18
More Details
2.1
EV/IC
EV/IC
Enterprise Value to IC
2.1
vs History
92
vs Industry
28
Median 3Y
4.4
Median 5Y
4.4
Industry
1.9
More Details

Multiples Across Competitors

Competitors Multiples
BioPlus Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
KR
BioPlus Co Ltd
KOSDAQ:099430
433B KRW 8.1 24.3 19.3 22.8
JP
Hoya Corp
TSE:7741
6.8T JPY 8.6 35.8 23.7 28.7
CH
Alcon AG
SIX:ALC
37.6B CHF 4.3 36.3 17.8 34.5
DK
Coloplast A/S
CSE:COLO B
179.6B DKK 6.6 35.6 22.9 26.9
US
Align Technology Inc
NASDAQ:ALGN
15.8B USD 4 35.7 18 21.7
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
52B CNY 11.7 28.1 24.4 24.4
CA
Bausch + Lomb Corp
NYSE:BLCO
6.3B USD 1.4 -17.2 16.7 55.8
KR
HLB Inc
KOSDAQ:028300
9.1T KRW 175.4 -49 -75.4 -71.1
US
Lantheus Holdings Inc
NASDAQ:LNTH
6.2B USD 4.1 14.5 10 11.3
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.7B USD 4.3 47.7 23.8 39
UK
ConvaTec Group PLC
LSE:CTEC
4.5B GBP 2.6 37.2 264.5 462.1
P/E Multiple
Earnings Growth P/E to Growth
KR
B
BioPlus Co Ltd
KOSDAQ:099430
Average P/E: 32.8
24.3
N/A N/A
JP
Hoya Corp
TSE:7741
35.8
52%
0.7
CH
Alcon AG
SIX:ALC
36.3
107%
0.3
DK
Coloplast A/S
CSE:COLO B
35.6
50%
0.7
US
Align Technology Inc
NASDAQ:ALGN
35.7
102%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.1
92%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -17.2 N/A N/A
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -49 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
14.5
69%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
47.7
159%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
37.2
208%
0.2
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
KR
B
BioPlus Co Ltd
KOSDAQ:099430
Average EV/EBITDA: 44.1
19.3
N/A N/A
JP
Hoya Corp
TSE:7741
23.7
51%
0.5
CH
Alcon AG
SIX:ALC
17.8
34%
0.5
DK
Coloplast A/S
CSE:COLO B
22.9
39%
0.6
US
Align Technology Inc
NASDAQ:ALGN
18
52%
0.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.4
103%
0.2
CA
Bausch + Lomb Corp
NYSE:BLCO
16.7
82%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -75.4 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
10
43%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
23.8
81%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
264.5
42%
6.3
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
KR
B
BioPlus Co Ltd
KOSDAQ:099430
Average EV/EBIT: 72.7
22.8
N/A N/A
JP
Hoya Corp
TSE:7741
28.7
N/A N/A
CH
Alcon AG
SIX:ALC
34.5
107%
0.3
DK
Coloplast A/S
CSE:COLO B
26.9
42%
0.6
US
Align Technology Inc
NASDAQ:ALGN
21.7
58%
0.4
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.4
87%
0.3
CA
Bausch + Lomb Corp
NYSE:BLCO
55.8
283%
0.2
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -71.1 N/A N/A
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.3
47%
0.2
US
Merit Medical Systems Inc
NASDAQ:MMSI
39
148%
0.3
UK
ConvaTec Group PLC
LSE:CTEC
462.1
96%
4.8

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.